Found: 4
Select item for more details and to access through your institution.
Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.
- Published in:
- Clinical & Experimental Immunology, 2016, v. 185, n. 2, p. 154, doi. 10.1111/cei.12806
- By:
- Publication type:
- Article
Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3<sup>+</sup> regulatory T cells.
- Published in:
- Clinical & Experimental Immunology, 2014, v. 178, n. 2, p. 253, doi. 10.1111/cei.12415
- By:
- Publication type:
- Article
Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic ( NOD). B6 ( Idd10/ Idd18) mice.
- Published in:
- Clinical & Experimental Immunology, 2014, v. 175, n. 2, p. 192, doi. 10.1111/cei.12224
- By:
- Publication type:
- Article
Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.
- Published in:
- Clinical & Experimental Immunology, 2009, v. 155, n. 3, p. 577, doi. 10.1111/j.1365-2249.2008.03837.x
- By:
- Publication type:
- Article